Known Medicine
Combining 3D cell culture & AI to translate drugs to clinical success
S20ActiveAI-powered Drug DiscoveryOncology
Combining 3D cell culture & AI to translate drugs to clinical success
Known Medicine combines patient-specific 3D cell culture & AI to translate drugs to clinical success. We receive patient tumors, break them down, make thousands of micro-tumors, and then treat each with different drugs to determine which they will respond best to.
Active Founders
Andrea Mazzocchi
- Research in tissue engineering, tumor microenvironments, cancer precision medicine - PhD, Biomedical Engineering at Wake Forest University - BS, Biomedical Engineering at Rochester Institute of Technology
Katie-Rose Skelly
- Led a team of PhD Data Scientists at Recursion Pharma (AI for drug discovery) - Stanford BS in Computer Science - Stanford MS in Biomedical Informatics
